Health Care Service Corporation says its prior authorization tool, first developed in 2021, can streamline the submission process and provide auto-approvals when certain key criteria are met.
WHY IT MATTERS
The prior auth tool was piloted on specialty pharmacy and behavioral health requests in…
From: www.healthcareitnews.com – Read more
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
